MCID: CRN038
MIFTS: 47

Carney Complex Variant malady

Categories: Genetic diseases, Rare diseases, Skin diseases

Aliases & Classifications for Carney Complex Variant

About this section

Aliases & Descriptions for Carney Complex Variant:

Name: Carney Complex Variant 49 11 22 67 65
Carney Complex 10 21 45 22 23 12 36 24 65
Carney Syndrome 10 21 45 22 23
Carney Complex, Type Ii 11 24
Carney Complex, Type 1 10 65
Lamb Syndrome 10 45
Name Syndrome 10 45
Car 45 2
Lamb - Lentigines, Atrial Myxoma, Mucocutaneous Myoma, Blue Nevus Syndrome 23
Name - Nevi, Atrial Myxoma, Skin Myxoma, Ephelides Syndrome 23
 
Myxoma-Spotty Pigmentation-Endocrine Overactivity Syndrome 45
Myxoma, Spotty Pigmentation, and Endocrine Overactivity 45
Myxoma - Spotty Pigmentation - Endocrine Overactivity 45
Myxoma-Spotty Pigmentation-Endocrine Overactivity 45
Carney Myxoma-Endocrine Complex 45
Carney Complex, Type 2 10
Familial Myxoma 22
Cacov 67
Cnc1 45

Characteristics:

HPO:

61
carney complex variant:
Inheritance: autosomal dominant inheritance


Classifications:



External Ids:

OMIM49 608837
Disease Ontology10 DOID:0050471
MeSH36 D056733
SNOMED-CT59 239132009
NCIt42 C4705
MedGen34 C1837245
UMLS65 C0406810, C1854540, C2607929 C1837245, more

Summaries for Carney Complex Variant

About this section
UniProtKB/Swiss-Prot:67 Carney complex variant: Carney complex is a multiple neoplasia syndrome characterized by spotty skin pigmentation, cardiac and other myxomas, endocrine tumors, and psammomatous melanotic schwannomas. Familial cardiac myxomas are associated with spotty pigmentation of the skin and other phenotypes, including primary pigmented nodular adrenocortical dysplasia, extracardiac (frequently cutaneous) myxomas, schwannomas, and pituitary, thyroid, testicular, bone, ovarian, and breast tumors. Cardiac myxomas do not develop in all patients with the Carney complex, but affected patients have at least two features of the complex or one feature and a clinically significant family history.

MalaCards based summary: Carney Complex Variant, also known as carney complex, is related to carney complex, type 1 and carney complex-trismus-pseudocamptodactyly syndrome, and has symptoms including trismus, distal arthrogryposis and cardiac myxoma. An important gene associated with Carney Complex Variant is MYH8 (Myosin, Heavy Chain 8, Skeletal Muscle, Perinatal), and among its related pathways are and 14-3-3 and Regulation of BAD Activity. Affiliated tissues include skin, bone and heart, and related mouse phenotypes are tumorigenesis and craniofacial.

Disease Ontology:10 An autosomal dominant disease characterized by myxomas, spotty pigmentation of the skin and endocrine overactivity.

Genetics Home Reference:23 Carney complex is a disorder characterized by an increased risk of several types of tumors. Affected individuals also usually have changes in skin coloring (pigmentation). Signs and symptoms of this condition commonly begin in the teens or early adulthood.

NIH Rare Diseases:45 Carney complex is an inherited condition characterized by spotty skin pigmentation, cardiac (heart) myxomas (tumors composed of mucous connective tissue), skin myxomas, endocrine tumors or over-activity, and schwannomas. some families with this condition have been found to have mutations in the prkar1a gene. carney complex is believed to be inherited in an autosomal dominant manner, which means that one copy of the altered gene in each cell is sufficient to cause the disorder. in most cases, an affected person inherits the mutation from one affected parent. last updated: 4/6/2015

CDC:2 Supported by CDC research, collaborations, or technical assistance (no staff or physical presence)

Description from OMIM:49 608837

GeneReviews summary for NBK1286

Related Diseases for Carney Complex Variant

About this section

Diseases in the Carney Complex Variant family:

Carney Complex, Type 1

Diseases related to Carney Complex Variant via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 48)
idRelated DiseaseScoreTop Affiliating Genes
1carney complex, type 112.7
2carney complex-trismus-pseudocamptodactyly syndrome11.8
3sarcoma10.5
4interdigitating dendritic cell sarcoma10.5
5dendritic cell sarcoma10.5
6lassa fever10.5
7somatomammotropinoma10.4AIP, MEN1
8lethal arteriopathy syndrome due to fibulin-4 deficiency10.4AIP, MEN1
9common bile duct disease10.3PRKAR1A, PRKAR1B
10alk-related neuroblastic tumor susceptibility10.3AIP, GNAS
11acth-independent macronodular adrenal hyperplasia10.2GNAS, PRKAR1A
12qazi markouizos syndrome10.2MEN1, PRKAR1A, PRKAR1B
13familial joint instability syndrome10.2AIP, CDKN1B
14serous labyrinthitis10.1GNAS, PRKAR1A, PRKAR1B
15pseudohypoparathyroidism, type ib10.1GNAS, PDE11A
16pituitary adenoma, prolactin-secreting10.1AIP, GNAS, PRKAR1B
17keratopathy10.1
18bullous keratopathy10.1
19blount's disease10.0PRKAR1A, PRKAR1B
20arteriovenous malformation10.0AIP, POMC
21pseudohypoparathyroidism ic10.0GNAS, MEN1, PRKAR1A, PRKAR1B
22acromegaly10.0AIP, POMC
23adrenal neuroblastoma10.0AIP, GNAS, MEN1, PRKAR1A
24low tension glaucoma10.0CDKN1B, MEN1, PRKAR1A
25autosomal recessive disease9.9
26pancreatic foamy gland adenocarcinoma9.9CDKN1B, GNAS
27sensory system cancer9.9POMC, PRKAR1A, PRKAR1B
28prolactin producing pituitary tumor9.9AIP, MEN1, POMC
29lung giant cell carcinoma9.9MEN1, POMC
30pancreas sarcoma9.9CDKN1B, GNAS
31central nervous system organ benign neoplasm9.9AIP, MEN1, POMC
32male reproductive organ benign neoplasm9.8AIP, MEN1, POMC
33gastric gastrinoma9.8MEN1, POMC
34functioning pituitary adenoma9.8AIP, MEN1, POMC
35adrenal gland pheochromocytoma9.8POMC, PRKAR1A
36cold-induced sweating syndrome 29.8AIP, GNAS, POMC
37adrenal carcinoma9.8GNAS, POMC, PRKAR1A
38postherpetic neuralgia9.7GNAS, MEN1, POMC
39immunodeficiency, common variable, 59.7CDKN1B, GNAS, MEN1, PRKAR1A
40adrenal cortical adenocarcinoma9.7PDE11A, POMC, PRKAR1A, PRKAR1B
41peripheral nerve schwannoma9.7PDE11A, POMC, PRKAR1A, PRKAR1B
42central retinal vein occlusion9.7AIP, GNAS, POMC
43organ system benign neoplasm9.6AIP, GNAS, MEN1, POMC
44craniopharyngioma9.6AIP, GNAS, MEN1, POMC
45non-invasive bladder urothelial carcinoma9.4AIP, GNAS, MEN1, POMC, PRKAR1A
46medulloadrenal hyperfunction9.3GNAS, PDE11A, PDE8B, POMC, PRKAR1A
47photosensitive epilepsy9.1PDE11A, PDE8B, POMC, PRKACB, PRKAR1A, PRKAR1B
48ataxia-oculomotor apraxia 37.3AIP, CDKN1B, F10, FOXI1, GNAS, MEN1

Graphical network of the top 20 diseases related to Carney Complex Variant:



Diseases related to carney complex variant

Symptoms for Carney Complex Variant

About this section


Clinical features from OMIM:

608837

HPO human phenotypes related to Carney Complex Variant:

id Description Frequency HPO Source Accession
1 trismus HP:0000211
2 distal arthrogryposis HP:0005684
3 cardiac myxoma HP:0011672

Drugs & Therapeutics for Carney Complex Variant

About this section

Drugs for Carney Complex Variant (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 16)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
PaclitaxelapprovedPhase 3262133069-62-436314
Synonyms:
(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
157069-30-2
33069-62-4
5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.
7-Epi-Paclitaxel
7-Epi-Taxol
7-Epipaclitaxel
7-Epitaxol
7-epi-Paclitaxel
7-epi-Taxol
AB00513812
ABI 007
ABI-007
ABI007
AC-675
AC1L1IOG
AC1L1VJI
AC1L9AVF
ACon1_002231
ANX-513
Abraxane
Abraxane (TN)
Abraxane I.V. Suspension
Abraxis BioScience brand of albumin-bound paclitaxel
Ambotz33069-62-4
Anzatax
Asotax
BIDD:PXR0046
BMS 181339-01
BMS-181339
BMS-181339-01
BPBio1_000320
BRD-A23723433-001-01-2
BRD-A28746609-001-04-0
BRD-K62008436-001-03-1
BSPBio_000290
BSPBio_001152
BSPBio_002614
Bio-0076
Bio1_000362
Bio1_000851
Bio1_001340
Bio2_000416
Bio2_000896
Bristaxol
C07394
C466458
C47H51NO14
CCRIS 8143
CHEBI:103439
CHEBI:45863
CHEMBL100910
CHEMBL418410
CHEMBL48
CID36314
CID441276
CID4666
CID6713921
CID6915727
CPD-8718
Capxol
D00491
DB01229
DHP-107
DHP-208
DRG-0190
DTS-301
DivK1c_000441
EU-0101201
Ebetaxel
EmPAC
Epitaxol
Genaxol
Genetaxyl
Genexol
Genexol-PM
HMS1362J13
HMS1568O12
HMS1792J13
HMS1922K08
HMS1990J13
HMS2090D07
HMS2093K15
HMS501G03
HSDB 6839
I06-0014
IDI1_000441
IDI1_002171
Intaxel
KBio1_000441
KBio2_000492
KBio2_002016
KBio2_002509
KBio2_003060
KBio2_004584
KBio2_005077
KBio2_005628
KBio2_007152
KBio2_007645
KBio3_000903
KBio3_000904
KBio3_001834
KBio3_002987
KBioGR_000492
KBioGR_001893
 
KBioGR_002509
KBioSS_000492
KBioSS_002016
KBioSS_002517
LMPR0104390001
LS-31070
LipoPac
Lopac0_001201
MBT 0206
MEGxp0_001940
MLS000863266
MLS001077297
MLS002154218
MLS002172439
MLS002695976
MPI-5018
Micellar Paclitaxel
Mitotax
MolPort-001-742-627
MolPort-003-665-783
MolPort-003-932-365
NCGC00024995-02
NCGC00024995-03
NCGC00024995-04
NCGC00024995-05
NCGC00024995-06
NCGC00024995-07
NCGC00164367-01
NCGC00164367-02
NCGC00164367-03
NCI60_000601
NINDS_000441
NK 105
NP-010981
NSC 125973
NSC-125973
NSC125973
NSC358882
Nanotaxel
Neuro_000060
Nova-12005
OAS-PAC-100
OncoGel
Onxal
Onxol
Onxol, Taxol, Nov-Onxol, Paclitaxel
P1632
Paclical
Pacligel
Paclitaxel
Paclitaxel (JAN/USP)
Paclitaxel (JAN/USP/INN)
Paclitaxel (Taxol)
Paclitaxel [USAN:INN:BAN]
Paxceed
Paxene
Paxoral
Plaxicel
Praxel
Prestwick0_000155
Prestwick1_000155
Prestwick2_000155
Prestwick3_000155
Probes2_000350
QW 8184
S-8184 Paclitaxel Injectable Emulsion
S1150_Selleck
SDCCGMLS-0066823.P001
SDP-013
SMP1_000228
SMR000394086
SMR000857385
SPBio_000943
SPBio_002229
SPECTRUM1503908
ST50306996
Spectrum2_000872
Spectrum3_001057
Spectrum4_001197
Spectrum5_001491
Spectrum_001536
T 7402
T1912_SIGMA
T7191_SIGMA
T7402_SIGMA
TA1
TAXOL (TN)
TAXOL, 10-EPI,
TXL
TaxAlbin
Taxol
Taxol A
Taxol Konzentrat
Taxol.RTM. (Registered Trademark)
UNII-P88XT4IS4D
UPCMLD-DP108:001
UPCMLD-DP108:002
Vascular Wrap
Xorane
Yewtaxan
abi-007
albumin-bound paclitaxel
cMAP_000068
nchembio.188-comp1
nchembio.2007.34-comp9
nchembio.215-comp9
nchembio853-comp6
paclitaxel
weekly paclitaxel
2
CisplatinapprovedPhase 3, Phase 2254015663-27-184093, 441203, 2767
Synonyms:
(SP-4-1)-diamminedichloridoplatinum
(SP-4-1)-diamminedichloroplatinum
(SP-4-2)-diamminedichloridoplatinum
(SP-4-2)-diamminedichloroplatinum
Abiplatin
Biocisplatinum
Briplatin
CACP
CDDP
CHEBI:35852
CID441203
CPD0-1392
CPDC
CPDD
Carboquone
Cis Pt II
Cis-DDP
Cis-Diaminedichloroplatinum
Cis-Diamminedichloroplatinum
Cismaplat
Cisplatin
Cisplatine
Cisplatino
Cisplatinum
Cisplatyl
Citoplationo
DB00515
DDP
DDPT
Diamminedichloroplatinum
 
EU-0100918
Lederplatin
Neoplatin
Peyrone's chloride
Peyrone's salt
Plastin
Platamine
Platiblastin
Platidiam
Platinex
Platinol
Platinol-AQ
Platinol-aq
Platinoxan
Platinum Ammine Chloride
Platinum Ammonium Chloride
Platinum Diamine Dichloride
Randa
Trans-DDP
Trans-Diaminedichloroplatinum
Trans-Diamminedichloroplatinum
Trans-Dichlorodiammine Platinum
Trans-Platinumdiammine Dichloride
cis-DDP
cis-Diamminedichloroplatinum
cis-Dichlorodiammineplatinum(II)
cis-[PtCl2(NH3)2]
cis-diamminedichloridoplatinum(II)
cis-diamminedichloroplatinum(II)
nchembio773-comp1
trans-diamminedichloridoplatinum(II)
3
CarboplatinapprovedPhase 3188541575-94-410339178, 498142, 38904
Synonyms:
(SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum
/h1-3H2,(H,7,8)(H,9,10)
/q
1,1-Cyclobutanedicarboxylate diammine platinum (II)
1,1-Cyclobutanedicarboxylate diammine platinum(II)
2*-1
2*1H2
41575-94-4
70903-55-8
AC-1457
AC1L8I6U
Ambap41575-94-4
BSPBio_003145
C 2538
C2043
C2538_SIGMA
C6H10N2O4Pt
CBDCA
CCRIS 3404
CHEBI:31355
CHEMBL1351
CHEMBL288376
CID10339178
CID2567
CID38904
CID426756
CID498142
CID5352133
CID6398587
CID6603770
Carbopaltin
Carboplatin
Carboplatin (JAN/USP/INN)
Carboplatin (USAN)
Carboplatin [USAN:INN:BAN:JAN]
Carboplatine
Carboplatine [French]
Carboplatino
Carboplatino [Spanish]
Carboplatinum
Carboplatinum [Latin]
Cbdca
Cyclobutane-1,1-dicarboxylate
D01363
DB00958
Diammine(1,1-cyclobutanedicarboxylato)platinum (II)
Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum
Diammine-1,1-cyclobutane dicarboxylate platinum II
DivK1c_000892
EINECS 255-446-0
EU-0100230
Ercar
HMS1921J16
HMS2090M05
HMS2092B22
HMS502M14
HSDB 6957
I14-2390
IDI1_000892
IUPAC: Azane
InChI=1/C6H8O4.2H2N.Pt/c7-4(8)6(5(9)10)2-1-3-6
 
JM 8
JM-8
KBio1_000892
KBio2_002009
KBio2_004577
KBio2_007145
KBio3_002645
KBioGR_000713
KBioSS_002009
LS-117689
Lopac-C-2538
Lopac0_000230
MolPort-003-665-501
MolPort-003-845-609
NCGC00015223-01
NCGC00093695-01
NCGC00094961-01
NCGC00094961-02
NCGC00094961-03
NCGC00162099-01
NCGC00162099-02
NCGC00167800-01
NCGC00178242-01
NINDS_000892
NSC 201345
NSC 241240
NSC-241240
NSC201345
NSC241240
Paraplatin
Paraplatin (TN)
Paraplatin, Carboplatin
Paraplatin-AQ
Platinum(+2) Cation
Platinum(II), (1, 1-cyclobutanedicar
Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)
Platinum, {diammine[1,1-cyclobut
S1215_Selleck
SPBio_000716
SPECTRUM1502106
Spectrum2_000898
Spectrum3_001503
Spectrum4_000337
Spectrum5_001094
Spectrum_001529
UNII-BG3F62OND5
azanide
carboplatin
cis -Diammine[1,1-cyclobutane-dicarboxylato] platinum
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II)
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(ii)
cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II)
cis-Diammine(1,1-cyclobutanedicarboxylato) platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diammine(cyclobutanedicarboxylato)platinum II
cyclobutane-1,1-dicarboxylic acid
diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum
nchembio.573-comp10
nchembio773-comp2
nchembio873-comp3
platinum(2+)
4
SuccinylcholineapprovedPhase 3, Phase 2141306-40-15314
Synonyms:
2,2'-[(1,4-DIOXOBUTANE-1,4-DIYL)BIS(OXY)]BIS(N,N,N-TRIMETHYLETHANAMINIUM)
2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)
2ha2
2ha6
306-40-1
4-04-00-01451 (Beilstein Handbook Reference)
541-19-5 (diiodide)
55-94-7 (dibromide)
71-27-2 (dichloride)
AC1L1K2T
Anectine
BRN 1805311
C07546
C14H30N2O4
CHEBI:45652
CHEMBL703
CID5314
Choline, succinate (2:1) (ester)
Choline, succinate (ester)
DB00202
Diacetylcholine
Dicholine succinate
Ditilin
Ditiline
HMS2090P14
HSDB 3254
InChI=1/C14H30N2O4/c1-15(2,3)9-11-19-13(17)7-8-14(18)20-12-10-16(4,5)6/h7-12H2,1-6H3/q+2
L000926
LS-53328
Listenon
 
Lopac-S-8251
Lopac0_001080
Lysthenon
MolPort-002-964-486
NCGC00015971-01
NCGC00015971-03
NCGC00162336-01
Quelicin
Quelicin Preservative Free
SCK
ST50437287
STK177290
Scoline
Succicuran
Succinic acid, diester with choline
Succinic acid, diester with choline chloride
Succinocholine
Succinoylcholine
Succinyl choline
Succinylbischoline
Succinylcholine
Succinylcholine Chloride
Succinyldicholine
Sucostrin
Suxamethonium
Suxamethonium chloride
UNII-J2R869A8YF
ZINC01530820
succinylcholine
succinyldicholine
trimethyl-[2-[4-oxo-4-(2-trimethylazaniumylethoxy)butanoyl]oxyethyl]azanium diio
trimethyl-[2-[4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl]oxyethyl]azanium
5Tubulin ModulatorsPhase 34279
6Peripheral Nervous System AgentsPhase 3, Phase 218510
7Albumin-Bound PaclitaxelPhase 32621
8Neuromuscular Depolarizing AgentsPhase 3, Phase 2116
9Neuromuscular Blocking AgentsPhase 3, Phase 2327
10Antineoplastic Agents, PhytogenicPhase 34294
11Antimitotic AgentsPhase 34296
12Neuromuscular AgentsPhase 3, Phase 2922
13
Epinephrineapproved83451-43-45816
Synonyms:
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol
(-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol
(-)-Adrenalin
(-)-Adrenaline
(-)-Epinephrine
(-)-R-Epinephrine
(R)-(-)-Adnephrine
(R)-(-)-Adrenaline
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-(−)-adrenaline
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-4-[1-hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
(R)-Adrenaline
(R)-Epinephrine
(−)-adrenaline
02252_FLUKA
1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
1-Adrenalin
1-Epinephrine
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
51-43-4
51-43-4 (FREE BASE)
51028-73-0
A0173
AC-13188
AC1L1L7B
ADR ADRENALINE
ADROP
AI3-19015
Adnephrine
Adrenaclick
Adrenal
Adrenalin
Adrenalin (TN)
Adrenalin in Oil
Adrenalin-Medihaler
Adrenalina
Adrenalina [DCIT]
Adrenaline
Adrenaline (JP15)
Adrenaline/Epinephrine
Adrenalinum
Adrenamine
Adrenan
Adrenapax
Adrenasol
Adrenatrate
Adrenine
Adrenodis
Adrenohorma
Adrenosan
Adrenutol
Adrin
Adrine
Ana-Guard
Ana-Kit
Antiasthmatique
Asmatane Mist
Asthma meter mist
Asthma-nefrin
Asthmahaler Mist
Asthmanefrin
Astmahalin
Astminhal
Auvi-q
BIDD:GT0119
Balmadren
Bernarenin
Biorenine
Bosmin
Brevirenin
Bronkaid
Bronkaid Mist
Bronkaid Suspension Mist
Bupivacaine Hcl and Epinephrine
C00788
CCRIS 4812
CHEBI:28918
CHEMBL679
CID5816
Chelafrin
Citanest Forte
Corisol
D-Epifrin
D-Epinephrine
D00095
DB00668
Drenamist
Dylephrin
Dyspne-Inhal
E4250_SIGMA
EINECS 200-098-7
EPI E Z PEN JR
EPIPEN E Z PEN
EPIPEN JR
Epi EZ Pen Jr
Epifrin
Epiglaufrin
Epinefrin
Epinefrin [Czech]
Epinefrina
Epinefrina [INN-Spanish]
Epinephran
Epinephrin
Epinephrine
Epinephrine (USP)
Epinephrine (USP/INN)
Epinephrine [USAN:INN:JAN]
Epinephrine bitartrate
Epinephrine chloride
Epinephrine hydrochloride
Epinephrinum
Epinephrinum [INN-Latin]
Epipen
Epipen (TN)
Epipen Auto-Injector
Epipen EZ Pen
Epipen Jr
Epipen Jr.
Epipen Jr. Auto-Injector
Epipen jr
Epirenamine
Epirenan
Epirenin
Epitrate
Eppy
 
Esphygmogenina
Exadrin
Glaucon
Glaucosan
Glauposine
Glycirenan
HSCI1_000215
HSDB 4289
Haemostasin
Haemostatin
Hektalin
Hemisine
Hemostasin
Hemostatin
Hypernephrin
Hyporenin
IOP
Intranefrin
Iontocaine
Isoptoepinal
Kidoline
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-Adrenaline
L-Adrenaline Base
L-Epinehphrine
L-Epinephrine
L-Epirenamine
L-Methylaminoethanolcatechol
L-epinephrine
LS-156
Levo-Methylaminoethanolcatechol
Levoadrenaline
Levoepinephrine
Levorenen
Levorenin
Levorenine
Levoreninum
Lopac-E-4642
Lyodrin
Lyophrin
Medihaler-Epi
Metanephrin
Methylaminoethanolcatechol
Methylarterenol
Micronefrin
Micronephrine
MolPort-002-051-368
Mucidrina
Myosthenine
Mytrate
NCGC00015417-01
NCGC00142615-01
NCGC00142615-03
NCGC00142615-04
NCGC00142615-05
NCGC00142615-06
NCGC00142615-07
NSC 62786
NSC62786
Nephridine
Nieraline
PDSP1_001120
PDSP2_001104
Paranephrin
Primatene
Primatene Mist
Primatene Mist Refill
Prime Asthma Relief
R-(-)-Epinephrine
R-Adrenaline
RCRA waste no. P042
Racemic Epinephrine
Racepinephrine
Rcra waste number P042
Renagladin
Renaglandin
Renaglandulin
Renaleptine
Renalina
Renoform
Renostypricin
Renostypticin
Renostyptin
SMP1_000227
ST069368
SUS-PHRINE SULFITE-FREE
Scurenaline
Septocaine
Simplene
Sindrenina
Soladren
Sphygmogenin
Stryptirenal
Styptirenal
Supracapsulin
Supradin
Supranefran
Supranephrane
Supranephrine
Supranol
Suprarenaline
Suprarenin
Suprel
Surenine
Surrenine
Sus-Phrine
Sus-phrine
Susphrine
Sympathin I
Takamina
Takamine
Tokamina
Tonogen
Twinject
Twinject 0.15
Twinject 0.3
Twinject 0.30
UNII-YKH834O4BH
Vaponefrin
Vasoconstrictine
Vasoconstrictor
Vasodrine
Vasoton
Vasotonin
adrenaline
bmse000316
d-Adrenaline
epinephrine
l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
l-Adrenalin
l-Adrenaline
l-Epinephine
l-Epinephrine (synthetic)
l-Epirenamine
l-Methylaminoethanolcatechol
levoepinephrine
nchembio747-comp9
14Hormones11748
15Epinephryl borate834
16Racepinephrine834

Interventional clinical trials:

idNameStatusNCT IDPhase
1Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical CancerRecruitingNCT01414608Phase 3
2Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent SurgeryRecruitingNCT01101451Phase 3
3Linsitinib in Treating Patients With Gastrointestinal Stromal TumorsCompletedNCT01560260Phase 2
4Radiation Therapy and Cisplatin With or Without Triapine in Treating Patients With Newly Diagnosed Stage IB2, II, or IIIB-IVA Cervical Cancer or Stage II-IVA Vaginal CancerRecruitingNCT02466971Phase 2
5Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney ComplexRecruitingNCT00001452
6Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations in AcromegalyRecruitingNCT01902420
7Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the CARNEY Complex (CNC)Active, not recruitingNCT00668291

Search NIH Clinical Center for Carney Complex Variant


Cochrane evidence based reviews: carney complex

Genetic Tests for Carney Complex Variant

About this section

Genetic tests related to Carney Complex Variant:

id Genetic test Affiliating Genes
1 Carney Complex22 PRKAR1A
2 Carney Complex Variant22 MYH8

Anatomical Context for Carney Complex Variant

About this section

MalaCards organs/tissues related to Carney Complex Variant:

33
Skin, Bone, Heart, Thyroid, Breast, Pituitary

Animal Models for Carney Complex Variant or affiliated genes

About this section

MGI Mouse Phenotypes related to Carney Complex Variant:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.6AIP, CDKN1B, MEN1, POMC, PRKAR1A
2MP:00053828.4CDKN1B, FOXI1, GNAS, MEN1, PRKAR1A
3MP:00053857.4AIP, CDKN1B, F10, GNAS, MEN1, POMC
4MP:00036316.9CDKN1B, FOXI1, GNAS, MEN1, PDE11A, POMC
5MP:00107686.5AIP, CDKN1B, F10, FOXI1, GNAS, MEN1
6MP:00053766.4AIP, CDKN1B, F10, FOXI1, GNAS, MEN1

Publications for Carney Complex Variant

About this section

Articles related to Carney Complex Variant:

idTitleAuthorsYear
1
Directed antisense therapy confirms the role of protein kinase C-alpha in the tumorigenicity of pancreatic cancer. (9706141)
1998

Variations for Carney Complex Variant

About this section

UniProtKB/Swiss-Prot genetic disease variations for Carney Complex Variant:

67
id Symbol AA change Variation ID SNP ID
1MYH8p.Arg674GlnVAR_019810rs28932773

Clinvar genetic disease variations for Carney Complex Variant:

5
id Gene Variation Type Significance SNP ID Assembly Location
1NM_002472.2(MYH8): c.2021G> A (p.Arg674Gln)single nucleotide variantPathogenicrs121434590GRCh37Chr 17, 10310241: 10310241

Expression for genes affiliated with Carney Complex Variant

About this section
Search GEO for disease gene expression data for Carney Complex Variant.

Pathways for genes affiliated with Carney Complex Variant

About this section

Pathways related to Carney Complex Variant according to GeneCards Suite gene sharing:

(show all 38)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.6
29.5PRKACB, PRKAR1A, PRKAR1B
39.5PRKACB, PRKAR1A, PRKAR1B
49.5PRKACB, PRKAR1A, PRKAR1B
59.5PRKACB, PRKAR1A, PRKAR1B
69.5PRKACB, PRKAR1A, PRKAR1B
79.5PRKACB, PRKAR1A, PRKAR1B
89.5PRKACB, PRKAR1A, PRKAR1B
99.5PRKACB, PRKAR1A, PRKAR1B
10
Show member pathways
9.5GNAS, PRKAR1A, PRKAR1B
11
Show member pathways
9.1GNAS, PRKACB, PRKAR1A, PRKAR1B
12
Show member pathways
9.1GNAS, PRKACB, PRKAR1A, PRKAR1B
13
Show member pathways
9.1GNAS, PRKACB, PRKAR1A, PRKAR1B
14
Show member pathways
9.1GNAS, PRKACB, PRKAR1A, PRKAR1B
15
Show member pathways
9.1GNAS, PRKACB, PRKAR1A, PRKAR1B
16
Show member pathways
9.1GNAS, PRKACB, PRKAR1A, PRKAR1B
17
Show member pathways
9.1GNAS, PRKACB, PRKAR1A, PRKAR1B
18
Show member pathways
9.1GNAS, PRKACB, PRKAR1A, PRKAR1B
19
Show member pathways
9.1GNAS, PRKACB, PRKAR1A, PRKAR1B
209.1GNAS, PRKACB, PRKAR1A, PRKAR1B
219.1GNAS, PRKACB, PRKAR1A, PRKAR1B
229.1GNAS, PRKACB, PRKAR1A, PRKAR1B
23
Show member pathways
9.1GNAS, PRKACB, PRKAR1A, PRKAR1B
249.1GNAS, PRKACB, PRKAR1A, PRKAR1B
259.1GNAS, PRKACB, PRKAR1A, PRKAR1B
26
Show member pathways
9.1GNAS, PRKACB, PRKAR1A, PRKAR1B
27
Show member pathways
9.1GNAS, PRKACB, PRKAR1A, PRKAR1B
28
Show member pathways
9.1GNAS, PRKACB, PRKAR1A, PRKAR1B
29
Show member pathways
9.1GNAS, PRKACB, PRKAR1A, PRKAR1B
30
Show member pathways
9.1GNAS, PRKACB, PRKAR1A, PRKAR1B
31
Show member pathways
8.9CDKN1B, PRKACB, PRKAR1A, PRKAR1B
32
Show member pathways
8.8GNAS, MYH8, PRKACB, PRKAR1A, PRKAR1B
338.7POMC, PRKACB, PRKAR1A, PRKAR1B
34
Show member pathways
8.5GNAS, PDE8B, PRKACB, PRKAR1A, PRKAR1B
358.3GNAS, PDE11A, PDE8B, POMC
36
Show member pathways
8.2GNAS, POMC, PRKACB, PRKAR1A, PRKAR1B
37
Show member pathways
7.7CDKN1B, F10, GNAS, PDE11A, PRKACB, PRKAR1A
38
Show member pathways
7.6CDKN1B, GNAS, POMC, PRKACB, PRKAR1A, PRKAR1B

GO Terms for genes affiliated with Carney Complex Variant

About this section

Cellular components related to Carney Complex Variant according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1ciliary baseGO:00975469.9PRKAR1A, PRKAR1B

Biological processes related to Carney Complex Variant according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of cAMP-dependent protein kinase activityGO:200048010.5PRKAR1A, PRKAR1B
2renal water homeostasisGO:000309110.2PRKAR1A, PRKAR1B
3water transportGO:00068339.7PRKACB, PRKAR1A, PRKAR1B
4cellular response to glucagon stimulusGO:00713779.5GNAS, PRKACB, PRKAR1A, PRKAR1B
5negative regulation of epithelial cell proliferationGO:00506809.4CDKN1B, MEN1
6energy reserve metabolic processGO:00061129.1GNAS, PRKACB, PRKAR1A, PRKAR1B
7fibroblast growth factor receptor signaling pathwayGO:00085439.0CDKN1B, PRKACB, PRKAR1A, PRKAR1B
8neurotrophin TRK receptor signaling pathwayGO:00480118.9CDKN1B, PRKACB, PRKAR1A, PRKAR1B

Molecular functions related to Carney Complex Variant according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
13,5-cyclic-AMP phosphodiesterase activityGO:00041159.6PDE11A, PDE8B

Sources for Carney Complex Variant

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet